Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Therapeutic homology-independent targeted integration in retina and liver

ABSTRACT: Therapeutic homology-independent targeted integration in retina and liver

PROVIDER: PRJNA666431 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Therapeutic homology-independent targeted integration in retina and liver

Project description:We report the integration of AAV using CRISPr techonology within Mus musculus targeting RHO and ALB genes.

2022-01-13 | GSE158759 | GEO

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.

Project description: Not available

| S-EPMC5331785 | biostudies-literature

Safe harbor-targeted CRISPR-Cas9 homology-independent targeted integration for multimodality reporter gene-based cell tracking.

Project description: Not available

| S-EPMC7817109 | biostudies-literature

A CRISPR/Cas9-Mediated, Homology-Independent Tool Developed for Targeted Genome Integration in Yarrowia lipolytica.

Project description: Not available

| S-EPMC8105018 | biostudies-literature

Efficient targeted integration in proliferating patient hepatocytes for inherited liver diseases

Project description:Hepatocyte transplantation has shown great potential for treating inherited liver diseases. However, its prolonged clinical therapeutic efficacy is still hindered by serious immune rejection from the host immunological responses to the allogeneic hepatocytes and there is still no an effective approach to generate clinically available autologous hepatocytes for transplantation therapy. Here, we report advanced medium conditions that allow 10,000-fold expansion of primary human hepatocytes from patients suffering inherited liver diseases, providing a new autologous hepatocytes source to this problem. Moreover, we developed a CRISPR–Cas9 genome-targeting system that combines Cas9 ribonucleoproteins and adeno-associated viral vector delivery of a homology-independent large donor (greater than three kilobase) to achieve efficient targeted integration at the AAVS1 safe harbor locus in patient-derived proliferating human hepatocytes (ProliHHs). We further applied this strategy to correct a pathogenic OTC and FAH mutation in ProliHHs and demonstrated improved gene expression, while preserving cell viability for the expansion and purification of edited ProliHHs. Importantly, these edited ProliHHs repopulate into injured mouse liver at a level near to primary human hepatocytes, and they undergo maturation to successfully treat the tyrosinemia mouse model following transplantation in vivo. Thus, this study provides a new autologous hepatocyte therapy techniques that enable large-scale expansion and ex vivo gene correction in patient-derived transplantable ProliHHs, which holds the potential for modeling and treating human liver disease.

2023-09-12 | GSE233425 | GEO

Integration-independent Transgenic Huntington Disease Fragment Mouse Models

Project description:Data from Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo CoIP of HTT full length and fragment proteins from mouse cortical lysates. Controlled with preimmune mouse IgG IP.

2015-06-30 | MSV000079178 | MassIVE

Retina cells

Project description:This SuperSeries is composed of the following subset Series: GSE33076: Linearity of amplification between gene expression values and the amounts of RNA in a retina cell group GSE33085: Transcriptome analysis of adult retina cell types GSE33088: Developmental time-course of adult cell-type-specific retina genes of amacrine cells Refer to individual Series

2011-11-30 | E-GEOD-33089 | biostudies-arrayexpress

Homology-mediated end joining-based targeted integration using CRISPR/Cas9.

Project description: Not available

| S-EPMC5518881 | biostudies-other

Mus musculus

Project description:In vivo genome editing via CRISPR-Cas9 mediated homology-independent targeted integration

| PRJNA311358 | ENA

Molecular anatomy of the developing human retina

Project description:Clinical and genetic heterogeneity associated with retinal diseases makes stem cell-based therapies an attractive strategy for personalized medicine. However, we have limited understanding of the timing of key events in the developing human retina, and in particular the factors critical for generating the unique architecture of the fovea and surrounding macula. Here we define three key epochs in the transcriptome dynamics of human retina from fetal day (D) 52 to 150. Coincident histological analyses confirmed the cellular basis of transcriptional changes and highlighted the dramatic acceleration of development in the fovea compared to peripheral retina. Human and mouse retinal transcriptomes show remarkable similarity in developmental stages, though morphogenesis was greatly expanded in humans. Integration of DNA accessibility data allowed us to reconstruct transcriptional networks controlling photoreceptor differentiation. Our studies provide insights into human retinal development and serve as resource for molecular staging of human stem cell-derived retinal organoids.

2017-12-07 | GSE104827 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data